This compound is primarily utilized in glycobiology research for studying carbohydrate-protein interactions, particularly in the context of immune responses and infectious diseases. It serves as a synthetic glycan mimic to investigate the binding specificity of lectins, antibodies, and other carbohydrate-recognizing proteins. In vaccine development, it is employed to design glycoconjugate vaccines targeting pathogens that exploit similar glycan structures for host cell invasion. Additionally, it is used in the development of diagnostic tools to detect specific antibodies or lectins in biological samples. Its acetylated form enhances stability and allows for precise structural modifications to study the role of specific glycan epitopes in biological processes.